Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 8Colorectal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Prostatic Neoplasms 3Neoplasms 3Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Motor Activity 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Colonic Neoplasms 2Wilms Tumor 1Venous Thromboembolism 1Uveal Melanoma 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Opioid-Related Disorders 1Neuroblastoma 1Neoplastic Cells, Circulating 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia 1Inflammation 1Hodgkin Disease 1Hepatic Veno-Occlusive Disease 1HPV Positive Oropharyngeal Squamous Cell Carcinoma 1Fibrosis 1

Interventions

Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Blood Specimen Collection 4Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1navitoclax 1maltodextrin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1Viusid 1Vitamin E 1Vitamin D 1Tenofovir 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fibrosis × Hematologic Tests × Clear all
NCT01492127 2015-04-23

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

University Hospital, Montpellier

Phase NA Unknown
64 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡